相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis B Current Status of Therapy and Future Therapies
Elias Spyrou et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)
Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection
Cui-Huan Tian et al.
MEDICINE (2019)
miR-19 targets PTEN and mediates high mobility group protein B1(HMGB1)-induced proliferation and migration of human airway smooth muscle cells
Changchun Hou et al.
PLOS ONE (2019)
The Modulation of Regulatory T Cells via HMGB1/PTEN/β-Catenin Axis in LPS Induced Acute Lung Injury
Min Zhou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkers
Yiyu Lu et al.
CHINESE MEDICINE (2019)
The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function
Saige L. Pompura et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
The current status and future directions of hepatitis B antiviral drug discovery
Liudi Tang et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B
Bin Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?
Ahmet Cagkan Inkaya et al.
MEDICINE (2017)
Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients
Kun Li et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Correlation between high mobility group box-1 protein and chronic hepatitis B infection with severe hepatitis B and acute-on-chronic liver failure: a meta-analysis
Yi-Bing Hu et al.
MINERVA MEDICA (2017)
Up-regulation of IL-12 expression in patients with chronic hepatitis B is mediated by the PI3K/Akt pathway
Hong-wei Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses
Sharad Shrestha et al.
NATURE IMMUNOLOGY (2015)
Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection
Yi Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
The PTEN/PI3K/Akt signaling pathway mediates HMGB1-induced cell proliferation by regulating the NF-κB/cyclin D1 pathway in mouse mesangial cells
Xiao-Juan Feng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
PTEN
Carolyn A. Worby et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
CD8+T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection
Wei Cao et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B
J. Li et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure
Geng-Lin Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Chinese medicine for treatment of chronic hepatitis B
Guqi Wang et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2012)
Significance of the Balance between Regulatory T (Treg) and T Helper 17 (Th17) Cells during Hepatitis B Virus Related Liver Fibrosis
Jing Li et al.
PLOS ONE (2012)
Inhibition of Viral Replication Downregulates CD4+CD25high Regulatory T Cells and Programmed Death-Ligand 1 in Chronic Hepatitis B
Xue-Ping Nan et al.
VIRAL IMMUNOLOGY (2012)
Traditional Chinese Medicine Syndrome Distribution in Chronic Hepatitis B Populations: A Systematic Review
Xiao-Xi Zeng et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2011)
The host-pathogen interaction during HBV infection: immunological controversies
Antonio Bertoletti et al.
ANTIVIRAL THERAPY (2010)
Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8(+) T cells in patients with chronic hepatitis B virus infection
Xuefen Li et al.
CELLULAR IMMUNOLOGY (2010)
Contemporary Clinical Research of Traditional Chinese Medicines for Chronic Hepatitis B in China: An Analytical Review
Lingyi Zhang et al.
HEPATOLOGY (2010)
Interleukin-17-Producing CD4(+) T Cells Increase with Severity of Liver Damage in Patients with Chronic Hepatitis B
Ji-Yuan Zhang et al.
HEPATOLOGY (2010)
T Regulatory Cells Maintain Intestinal Homeostasis by Suppressing γδ T Cells
Sung-Gyoo Park et al.
IMMUNITY (2010)
Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B
Jian Ge et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B
Yufu Ye et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Myeloid PTEN Promotes Inflammation but Impairs Bactericidal Activities during Murine Pneumococcal Pneumonia
Gernot Schabbauer et al.
JOURNAL OF IMMUNOLOGY (2010)
Protein Kinase B/Akt Signals Impair Th17 Differentiation and Support Natural Regulatory T Cell Function and Induced Regulatory T Cell Formation
Mandy Pierau et al.
JOURNAL OF IMMUNOLOGY (2009)
Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load
Jing You et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation
R Palumbo et al.
JOURNAL OF CELL BIOLOGY (2004)
Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: A meta-analysis of randomized. controlled trials
M McCulloch et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2002)
分享论文
